statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced initial...

Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome during ASGCT Annual Meeting

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial...

Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting

The latest update is out from Neurogene (NGNE). Neurogene Inc. has struck new employment deals with its top executives, setting significant compens...

Neurogene Enhances Executive Compensation and Severance Terms

This is a signal that NGNE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Neurogene (NGNE, $46.64) RSI Indicator left the overbought zone on April 01, 2024

Neurogene Inc. (NGNE) has released an update. Neurogene Inc., a biotech firm listed on The Nasdaq Global Market under the ticker NGNE, has recently...

Neurogene Inc. Files Key SEC Report

Neurogene Inc. (NASDAQ:NGNE  Get Free Report)s stock price shot up 5.2% during mid-day trading on Monday . The company traded as high as $52.52 and last traded at $52.48. 30,491 shares...

Neurogene (NASDAQ:NGNE) Trading Up 5.2%

Neurogene Inc. (NASDAQ:NGNE  Free Report)  Research analysts at HC Wainwright issued their FY2025 earnings estimates for Neurogene in a research note issued on Tuesday, March 19th...

Neurogene Inc. Expected to Earn FY2025 Earnings of ($4.15) Per Share (NASDAQ:NGNE)

Key Financials and Clinical Trial Updates HighlightedRelated Stocks: NGNE...

Neurogene Inc (NGNE) Reports Financial Results for Q4 and Full Year 2023

This is a Bullish indicator signaling NGNE's price could rise from here. Traders may explore going long the stock or buying call options...

Neurogene (NGNE, $45.06) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 19, 2024

This price move could be a signal that NGNE may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Neurogene (NGNE, $45.06) price may drop as it broke higher Bollinger Band on Mar 19, 2024

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in January 2018 and is headquartered in New York, NY.

Watchers	71
52-Wk Low	$12.20
52-Wk High	$53.00

Volume	60,719.00
52-Wk High	$53.00
52-Wk Low	$12.20

NGNE Neurogene Inc

About

Feed

News

Sentiment

Fundamentals